Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype

Suzanne Craft*, Sanjay Asthana, Gerard Schellenberg, Laura Baker, Monique Cherrier, Adam A. Boyt, Ralph N. Martins, Murray Raskind, Elaine Peskind, Stephen Plymate

*Corresponding author for this work

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Higher fasting plasma insulin levels and reduced CSF-to-plasma insulin ratios, suggestive of insulin resistance, have been observed in patients with Alzheimer's disease (AD) who do not possess an apolipoprotein E (ApoE)-ε4 allele. Insulin has also been implicated in processing of β-amyloid and amyloid precursor protein (APP) We examined the effects of intravenous Insulin administration while maintaining euglycemia on insulin-mediated glucose disposal, memory, and plasma APP in patients with AD and normal adults of varying ApoE genotypes. AD subjects without an ε4 allele had significantly lower insulin-mediated glucose disposal rates than did AD patients with an ε4 allele (p < 0.03) or than did normal adults without an ε4 allele (p < 0.02). AD subjects without an ε4 allele also showed significant memory facilitation with insulin administration (p < 0.04), whereas the AD-ε4 group did not. Insulin reduced APP levels for AD patients without an ApoE ε4 allele, but raised APP for AD patients with an ApoE εH4 allele. These results document ApoE-related differences in insulin metabolism in AD that may relate to disease pathogenesis.

Original languageEnglish
Pages (from-to)222-228
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume903
Publication statusPublished - 2000
Externally publishedYes

Fingerprint Dive into the research topics of 'Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype'. Together they form a unique fingerprint.

  • Cite this